Anti-Human MS4A1 Therapeutic Antibody (Ibritumomab Tiuxetan)
Recombinant Mouse antibody to Human MS4A1. Ibritumomab tiuxetan, sold under the trade name Zevalin, is a monoclonal antibody radioimmunotherapy treatment for relapsed or refractory, low grade or transformed B cell non-Hodgkin's lymphoma, a lymphoproliferative disorder. The drug uses the monoclonal mouse IgG1 antibody ibritumomab (pronounced as ) in conjunction with the chelator tiuxetan, to which a radioactive isotope (either yttrium-90 or indium-111) is added. Tiuxetan is a modified version of DTPA whose carbon backbone contains an isothiocyanatobenzyl and a methyl group.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-H39 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | MS4A1 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | FC, IP, ELISA, Neut, FuncS, IF, ICC, PK |